Center on Health Equity & Access
Clinical
Health Care Cost
Health Care Delivery
Insurance
Policy
Technology
Value-Based Care

Biosimilars Cardiorenalmetabolic Dermatology Hematology Hepatology Immunology Infectious Disease Mental Health Neurology Obesity Oncology Ophthalmology Pulmonology Rare Disease Respiratory Rheumatology Women's Health

Free In-Person Regional Events Focused on Oncology and Population Health

Biosimilars Center on Health Equity & Access Digital Health Formulary Gene Therapy Guidelines Health Care Administration Health Care Cost Health Care Delivery Insurance Policy Population Health Product Approvals and Launches Technology Value-Based Care

All Coverage Event Coverage Interviews News

AJMC Journals Anniversary Author Forms Authors Nominate a Rising Leader Submit a Manuscript

Diabetes Therapy and Cardiovascular Outcomes: An Update

home / peer-exchange / diabetes-therapy-and-cardiovascular-outcomes-an-update

Impact of the EMPA-REG Study in Type 2 Diabetes

EP. 1: Impact of the EMPA-REG Study in Type 2 Diabetes

Watch

Cardiovascular Outcomes With GLP-1 Receptor Agonists in Type 2 Diabetes

EP. 2: Cardiovascular Outcomes With GLP-1 Receptor Agonists in Type 2 Diabetes

Watch

SGLT2 Inhibition and CVD Outcomes in Type 2 Diabetes

EP. 3: SGLT2 Inhibition and CVD Outcomes in Type 2 Diabetes

Watch

Cardiovascular Outcomes Trials With Anti-Diabetes Medications

EP. 4: Cardiovascular Outcomes Trials With Anti-Diabetes Medications

Watch

Understanding Heart Failure in Diabetes

EP. 5: Understanding Heart Failure in Diabetes

Watch

Big Data and CVD Benefits of Anti-Diabetes Medications

EP. 6: Big Data and CVD Benefits of Anti-Diabetes Medications

Watch

Designing Better Cardiovascular Outcomes Trials in Diabetes

EP. 7: Designing Better Cardiovascular Outcomes Trials in Diabetes

Watch

Big Data Analysis and Clinical Decision Making in Diabetes

EP. 8: Big Data Analysis and Clinical Decision Making in Diabetes

Watch

Cost-Effectiveness and Coverage Decisions in Diabetes

EP. 9: Cost-Effectiveness and Coverage Decisions in Diabetes

Watch

Shared Decision-Making in Diabetes

EP. 10: Shared Decision-Making in Diabetes

Watch

A Historic View on CV Outcomes in Diabetes

EP. 11: A Historic View on CV Outcomes in Diabetes

Watch

Impact of EMPA-REG OUTCOME

EP. 12: Impact of EMPA-REG OUTCOME

Watch

Results From the CANVAS Trial

EP. 13: Results From the CANVAS Trial

Watch

Complexities in Diabetes Care in 2017

EP. 14: Complexities in Diabetes Care in 2017

Watch

Diabetes: Shifting the Mindset for Cardiovascular Benefits

EP. 15: Diabetes: Shifting the Mindset for Cardiovascular Benefits

Watch

Cardiovascular Benefit With SGLT2 Inhibition

EP. 16: Cardiovascular Benefit With SGLT2 Inhibition

Watch

GLP-1 Receptor Agonists: Initial Cardiovascular Evidence

EP. 17: GLP-1 Receptor Agonists: Initial Cardiovascular Evidence

Watch

Understanding Cardiovascular Benefit With the LEADER Trial

EP. 18: Understanding Cardiovascular Benefit With the LEADER Trial

Watch

Impact of Cardiovascular Evidence on Diabetes

EP. 19: Impact of Cardiovascular Evidence on Diabetes

Watch

Editorial Boards

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences
AJMC®
All rights reserved.